Skip to content

Mannkind MNKD Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
Opko Health logo
Opko HealthOPK
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
Merit Medical Systems logo
Merit Medical SystemsMMSI
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B-50.6%
Enterprise value$1.15B-52.2%
P/E228.5×
P/S3.3×-4.8×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's accrued liabilities, current?
Mannkind (MNKD) reported accrued liabilities, current of $58.6M in Q1 2026.
How has Mannkind's accrued liabilities, current changed year-over-year?
Mannkind's accrued liabilities, current increased by 46.1% year-over-year, from $40.1M to $58.6M.
What is the long-term trend for Mannkind's accrued liabilities, current?
Over 5 years (2020 to 2025), Mannkind's accrued liabilities, current has grown at a 26.8% compound annual growth rate (CAGR), from $19.71M to $64.63M.